Atlas Trials

Bortezomib for Immunoglobulin Light Chain(AL) Amyloidosis

Clinical trial NCT02485613 · COMPLETED

Trial details

NCT number
NCT02485613
Sponsor
Zhi-Hong Liu, M.D.
Status
COMPLETED
Study type
OBSERVATIONAL
Amyloidosis
Start date
2009-01-01
Primary completion
2014-12-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.